Yearly Publication Trends - nanomedicine

Year	Publication Count
2024	812
2023	1957
2022	1136
2021	935
2020	746
2019	536
2018	345
2017	339
2016	308
2015	236
2014	224

Relevant Publications

Reactive oxygen species produced by photodynamic therapy enhance docosahexaenoic acid lipid peroxidation and induce the death of breast cancer cells.

Issue Release: 2024

Advancements in nanomedicine: Precision delivery strategies for male pelvic malignancies - Spotlight on prostate and colorectal cancer.

Issue Release: 2024

Light-driven rGO/CuO tubular nanomotor with active targeted drug delivery for combination treatment of cancer cells.

Issue Release: 2024

A robotic system for automated chemical synthesis of therapeutic agents.

Issue Release: 2024

Induction of antigen-specific immunity by mesoporous silica nanoparticles incorporating antigen peptides.

Issue Release: 2024

Democratizing FLASH Radiotherapy.

Issue Release: 2024

Targeted inhibition of pyroptosis a carbonized nanoinhibitor for alleviating drug-induced acute kidney injury.

Issue Release: 2024

Clinical translation of nanomedicine with integrated digital medicine and machine learning interventions.

Issue Release: 2024

Designing functionalized nanodiamonds with hyaluronic acid-phospholipid conjugates for enhanced cancer cell targeting and fluorescence imaging capabilities.

Issue Release: 2024

Advanced nanomedicines and immunotherapeutics to treat respiratory diseases especially COVID-19 induced thrombosis.

Issue Release: 2024

Plant Virus-Like Particles for RNA Delivery.

Issue Release: 2024

Hydroxyethyl starch-based self-reinforced nanomedicine inhibits both glutathione and thioredoxin antioxidant pathways to boost reactive oxygen species-powered immunotherapy.

Issue Release: 2024

Advanced Nanomedicine Approaches for Myocardial Infarction Treatment.

Issue Release: 2024

Facile synthesis of elastin nanogels encapsulated decursin for castrated resistance prostate cancer therapy.

Issue Release: 2024

Nanospheres for curcumin delivery as a precision nanomedicine in cancer therapy.

Issue Release: 2024

Neuroprotective macromolecular methylprednisolone prodrug nanomedicine prevents glucocorticoid-induced muscle atrophy and osteoporosis in a rat model of spinal cord injury.

Issue Release: 2024

Size-Dependent Glioblastoma Targeting by Polymeric Nanoruler with Prolonged Blood Circulation.

Issue Release: 2024

Transition-Metal-Oxide-Based Nanozymes for Antitumor Applications.

Issue Release: 2024

Tumor microenvironment reprogramming improves nanomedicine-based chemo-immunotherapy in sarcomas.

Issue Release: 2024

Acid-Responsive Decomposable Nanomedicine Based on Zeolitic Imidazolate Frameworks for Near-Infrared Fluorescence Imaging/Chemotherapy Combined Tumor Theranostics.

Issue Release: 2024

How to Overcome Regulatory and Ethical Concerns?

What Are the Risks of Dermal Contact?

What are the Environmental Implications of Using Nanotechnology?

What are the Challenges in Using Nanotechnology Lab Equipment?

What is the Future of Metallic Nanocompounds?

What are the Challenges in Working with Nanolayers?

How are Nanomaterials Tested for Mutagenicity?

What are some challenges associated with microscope technology in Nanotechnology?

How Can One Evaluate the Effectiveness of Science Communication in Nanotechnology?

What initiatives has the IAEA undertaken in the field of Nanotechnology?

Partnered Content Networks

Relevant Topics